Cas no for 179324-69-7,Bortezomib ACID Cas number search msds database,online free cas number chemistry search engine,cas number sigma aldrich

Post Sourcing Request Exhibition

Home > CAS No. Inquiry > 179324-69-7

[CAS Name] Bortezomib

[Formula] C19H25BN4O4

Search Products Post Sourcing Request

[CAS Name]Bortezomib
[Alias]VELCADE; dpba; [(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid; VELCADE(BORTEZOMIB); Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-; Bortezomib for research; N-[(1S)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-D-phenylalaninamide; N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide
[Number]179324-69-7
[EINECS]
[Formula]C19H25BN4O4
[Molecular weight]384.2372

179324-69-7 Suppliers

Company

Main Products

SHANGHAI FINETECH PHARM CO., LTD	please call me ， to know more	Send Inquiry
Hainan Shuangcheng Pharmaceuticals Co.,Ltd.	U.S. DMF in Preparation	Send Inquiry
Quanzhou Fortune Biopharma Co.,Ltd.	Bortezomib is the first proteasome inhibitor approved by the U.S. FDA for multiple myeloma, a blood cancer. Reversible inhibitor of 26S proteasome, a bark-shaped polyprotein particle, found in the nucleus and cytoplasm of all eukaryotic cells. Targeting the ubiquitin-proteasome pathway.	Send Inquiry